Mepolizumab and OCS Use in Eosinophilic Granulomatosis With Polyangiitis
A post-hoc analysis of the MIRRA trial of mepolizumab assessed the corticosteroid-sparing effect of mepolizumab in patients with EGPA.
ACAAI 2021
Omalizumab Efficacy for Allergic Asthma in Children of Varying Racial Backgrounds
Is omalizumab equally efficacious in treating allergic asthma among children from varying racial/ethnic backgrounds?
Safety and Efficacy of House Dust Mite Sublingual Immunotherapy Tablet
How effective are house dust mite sublingual immunotherapy tablets in controlling allergic rhinitis/conjunctivitis in adults and adolescents?
Managing Patients Experiencing Adverse Events After COVID-19 Vaccination
A recent study demonstrates an approach for evaluating and managing patients with adverse events following immunization with the COVID-19 vaccine.
Association Between Eosinophilic Esophagitis, Atopic Disease, and IBD in Children
Research presented at ACAAI 2021 assessed associations between IBD, eosinophilic esophagitis, esophageal eosinophilia, and atopic disease in children.
Trial Shows Mechanism of Oral Immunotherapy in Peanut Allergy Desensitization
How does oral immunotherapy succeed in stopping individuals with peanut allergies from experiencing an allergic reaction to peanuts?
CHRONICLE Trial Identifies Exacerbation Triggers of Severe Asthma
CHRONICLE investigators reported results of a patient survey on common asthma triggers at ACAAI 2021.
Dupilumab Improves Chronic Rhinosinusitis With Nasal Polyps, Comorbid Asthma
The SINUS-24/52 trial evaluated dupilumab’s impact on CRSwNP and comorbid asthma, looking at baseline asthma characteristics.
Initiate Biologic Therapy Sooner in Uncontrolled Severe Asthma?
In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma.
Can a Patient’s Asthma Impairment and Risk Questionnaire Score Predict HRQoL?
Asthma control as measured by AIRQ may predict 12-month HRQoL, according to research reported at the 2021 ACAAI Annual Scientific Meeting.
- Loading...
Loading...
Next post in ACAAI 2021
Loading... 
Loading...